Overview

• Seed round totals $4.5 million led by Nexus Venture Partners with 4CAST participating alongside Kriscore Capital and angels including Sriharsha Majety, Abhishek Goyal, Ritesh Malik, Arjun Vaidya and Stuart Broad.
• The company says it has launched a 12‑month post‑surgery insurance policy valid in the UK to cover complications after treatment abroad, describing it as a world‑first.
• Funds will support expansion across the UK and India, upgrades to digital patient management, stronger clinical partnerships and technology scaling, with planned entry into the US, Canada, Australia and Europe over the next few years.
• TMTC reports partnerships with Indian providers such as Fortis, Max Healthcare and Nova IVF Fertility and says care will be delivered in accredited hospitals with UK physician involvement.
• Founders Ankit Mehrotra and Sahil Jain, who sold Dineout to Swiggy in 2022, are positioning the platform for patients affected by long NHS elective waitlists—reported at roughly 7.7–8 million—with about 500,000 UK residents traveling abroad for care each year; valuation was not disclosed.